Schonfeld Strategic Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.77M | Buy |
+200,061
| New | +$5.67M | 0.05% | 404 |
|
|
2025
Q3 | – | Sell |
-46,346
| Closed | -$1.54M | – | 2165 |
|
|
2025
Q2 | $1.54M | Buy |
46,346
+22,746
| +96% | +$689K | 0.01% | 1113 |
|
|
2025
Q1 | $691K | Sell |
23,600
-7,552
| -24% | -$251K | ﹤0.01% | 1444 |
|
|
2024
Q4 | $1.02M | Buy |
31,152
+130
| +0.4% | +$6.11K | 0.01% | 1101 |
|
|
2024
Q3 | $1.38M | Sell |
31,022
-433,099
| -93% | -$19.7M | 0.01% | 1038 |
|
|
2024
Q2 | $20M | Buy |
+464,121
| New | +$16.8M | 0.13% | 166 |
|
|
2023
Q1 | – | Sell |
-23,700
| Closed | -$665K | – | 2057 |
|
|
2022
Q4 | $665K | Buy |
+23,700
| New | +$668K | 0.01% | 1363 |
|
|
2022
Q1 | – | Sell |
-11,300
| Closed | -$371K | – | 2558 |
|
|
2021
Q4 | $371K | Buy |
+11,300
| New | +$455K | ﹤0.01% | 1420 |
|
|
2021
Q3 | – | Sell |
-22,035
| Closed | -$1.21M | – | 2122 |
|
|
2021
Q2 | $1.21M | Sell |
22,035
-5,701
| -21% | -$319K | 0.01% | 866 |
|
|
2021
Q1 | $1.43M | Buy |
+27,736
| New | +$1.37M | 0.02% | 768 |
|
|
2020
Q4 | – | Sell |
-22,428
| Closed | -$785K | – | 1536 |
|
|
2020
Q3 | $785K | Buy |
22,428
+16,094
| +254% | +$705K | 0.01% | 774 |
|
|
2020
Q2 | $339K | Sell |
6,334
-134
| -2% | -$6.21K | 0.01% | 953 |
|
|
2020
Q1 | $229K | Buy |
+6,468
| New | +$299K | 0.01% | 860 |
|
|
2016
Q4 | – | Sell |
-11,000
| Closed | -$581K | – | 532 |
|
|
2016
Q3 | $581K | Buy |
+11,000
| New | +$479K | 0.1% | 254 |
|
|
2016
Q2 | – | Sell |
-7,841
| Closed | -$318K | – | 420 |
|
|
2016
Q1 | $318K | Buy |
+7,841
| New | +$335K | 0.13% | 210 |
|
Other funds holding AGIO
FCM
AC
VCM
LCM
VPM
EAM